Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Radiation Oncology Journal
>
2017
>
35
>
3
Volume:
35
Issue:
3
1. Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.
Page:189—197
2. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials.
Page:198—207
3. Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer.
Page:208—216
4. Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
Page:217—226
5. Clinical significance of the lymph node ratio in N1 breast cancer.
Page:227—232
6. Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Page:233—240
7. Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer.
Page:241—248
8. Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.
Page:189—197
9. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
Page:249—256
10. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials.
Page:198—207
11. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.
Page:257—267
12. Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer.
Page:208—216
13. Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Page:268—273
14. Gross tumor volume dependency on phase sorting methods of four-dimensional computed tomography images for lung cancer.
Page:274—280
15. Clinical significance of the lymph node ratio in N1 breast cancer.
Page:227—232
16. Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.
Page:281—288
17. Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Page:289—294
18. Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer.
Page:241—248
19. Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.
Page:257—267
20. Gross tumor volume dependency on phase sorting methods of four-dimensional computed tomography images for lung cancer.
Page:274—280
21. Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
Page:289—294
22. Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
Page:217—226
23. Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
Page:233—240
24. Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
Page:249—256
25. Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
Page:268—273
26. Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.
Page:281—288
